Advertisement

Topics

Edison Issues Outlook on Photocure (PHO)

08:57 EST 13 Nov 2017 | FinanzNachrichten

LONDON, UK / ACCESSWIRE / November 13, 2017 / Photocure (OTC PINK: PHCUF, OSE: PHO) is a commercial-stage Norwegian specialty pharmaceutical company that currently markets Hexvix/Cysview for diagno...

Original Article: Edison Issues Outlook on Photocure (PHO)

NEXT ARTICLE

More From BioPortfolio on "Edison Issues Outlook on Photocure (PHO)"

Advertisement
Quick Search
Advertisement
Advertisement